Stocks Health care YARW
NASDAQ · Health careYarrow Bioscience, Inc. (YARW)
Yarrow Bioscience, Inc. reported revenue of $570K in fiscal 2025, up 13.8% from a year earlier. It posted a net loss of $26.5M. In fiscal 2025 capital spending exceeded operating cash flow by $33.1M. At June 30, 2026 it held $22.9M in cash. Its latest periodic report to the SEC is the quarterly report (10-Q) filed on August 13, 2026.
What Yarrow Bioscience, Inc. does
Yarrow Bioscience, Inc. is registered with the SEC under industry code SIC 2834 (Pharmaceutical Preparations). Its shares trade on NASDAQ under the ticker YARW.
Revenue and profit by year
Key figures
| Fiscal year | Revenue | Net income | Diluted EPS | Free cash flow |
|---|---|---|---|---|
| 2025 | $570K | -$26.5M | -$0.62 | -$33.1M |
| 2024 | $501K | -$39.8M | -$0.93 | -$34.1M |
| 2023 | $424K | -$28.5M | -$2.78 | -$25.3M |
| 2022 | $477K | -$23.2M | -$7.28 | n/a |
| 2021 | $931K | -$73.3M | -$25.64 | -$56.4M |
| 2020 | $21M | -$255.6M | $7.88 | -$137.2M |
Latest SEC filings
What Yarrow Bioscience, Inc. has filed recently, newest first. Each links to the original document on SEC EDGAR.
- September 17, 2026Passive stake (5% or more) SCHEDULE 13G
- September 14, 2026
- September 11, 2026
- September 11, 2026
- September 10, 2026Other event 8-K
- August 14, 2026Passive stake (5% or more) SCHEDULE 13G
- August 14, 2026Passive stake (5% or more) SCHEDULE 13G
- August 14, 2026Form POS AM filing POS AM
- August 13, 2026Quarterly results 8-K/A
- August 13, 2026Quarterly report 10-Q · period to June 30, 2026
Questions about YARW
What does Yarrow Bioscience, Inc. do?
Yarrow Bioscience, Inc. is registered with the SEC under industry code SIC 2834 (Pharmaceutical Preparations). Its shares trade on NASDAQ under the ticker YARW.
Is Yarrow Bioscience, Inc. profitable?
No. In fiscal 2025 it reported a net loss of $26.5M on revenue of $570K.
How much revenue does Yarrow Bioscience, Inc. make?
In fiscal 2025 Yarrow Bioscience, Inc. reported revenue of $570K. That is 13.8% more than a year earlier.
When did Yarrow Bioscience, Inc. last report?
Its most recent periodic report is the quarterly report (10-Q) filed on August 13, 2026. It covers the period to June 30, 2026. Its newest filing of any kind is the passive stake (5% or more) from September 17, 2026.
Similar companies
Follow YARW
Get an email when Yarrow Bioscience, Inc. files with the SEC: results, executive changes, material agreements and annual reports.
Follow YARW: get an email when it filesWhere the numbers come from
Financial figures are the values Yarrow Bioscience, Inc. tagged in its own SEC filings (XBRL), taken from the latest filing for each period, so restatements replace older figures. Revenue, profit and cash flow are for full fiscal years unless marked as the last twelve months, which is the sum of the four most recent quarters. Where a company reports only the full year, the fourth quarter is the year minus the first three.
Prices are delayed end-of-day market data in the listing currency, and market cap moves with the price. P/E is shown only when earnings per share are positive. Nothing here is investment advice.